Thank you, Mr. Chair.
I'm going to continue my questions with Mr. Adams.
Mr. Adams, earlier today, a group of witnesses told us it was important to ensure that the expert committee that is struck isn't a pro forma group, by which I mean one that has no actual responsibility or that has an advisory role. Those witnesses asked that the pharmacare advisory and national strategy implementation groups be given the information they need to provide genuine advice rather than serve as a sounding board or merely provide tacit approval of decisions made in camera. Do you agree with that? What you have to say to us about that?